A Systematic Review of Commercial Hybrid Closed-Loop Automated Insulin Delivery Systems.

ABSTRACT:

Introduction

Several different forms of automated insulin delivery systems (AID systems) have recently been developed and are now licensed for type 1 diabetes (T1D). We undertook a systematic review of reported trials and real-world studies for commercial hybrid closed-loop (HCL) systems.

Methods

Pivotal, phase III and real-world studies using commercial HCL systems that are currently approved for use in type 1 diabetes were reviewed with a devised protocol using the Medline database.

Results

Fifty-nine studies were included in the systematic review (19 for 670G; 8 for 780G; 11 for Control-IQ; 14 for CamAPS FX; 4 for Diabeloop; and 3 for Omnipod 5). Twenty were real-world studies, and 39 were trials or sub-analyses. Twenty-three studies, including 17 additional studie

SUBMITTER: Peacock S 

PROVIDER: S-EPMC10126177 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature